Funding Rounds
AbolerIS Pharma

AbolerIS Pharma Series A (2023, $29M)

AbolerIS Pharma

Therapeutic platform focused on developing treatments that promote immune tolerance.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $29.16M

Investors